GB202108802D0 - Collagen type XX assay - Google Patents

Collagen type XX assay

Info

Publication number
GB202108802D0
GB202108802D0 GBGB2108802.6A GB202108802A GB202108802D0 GB 202108802 D0 GB202108802 D0 GB 202108802D0 GB 202108802 A GB202108802 A GB 202108802A GB 202108802 D0 GB202108802 D0 GB 202108802D0
Authority
GB
United Kingdom
Prior art keywords
assay
collagen type
collagen
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2108802.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordic Bioscience AS
Original Assignee
Nordic Bioscience AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordic Bioscience AS filed Critical Nordic Bioscience AS
Priority to GBGB2108802.6A priority Critical patent/GB202108802D0/en
Publication of GB202108802D0 publication Critical patent/GB202108802D0/en
Priority to PCT/EP2022/066635 priority patent/WO2022263675A1/en
Priority to JP2023574821A priority patent/JP2024525130A/ja
Priority to EP22735384.4A priority patent/EP4356137B1/en
Priority to KR1020237041627A priority patent/KR20240022470A/ko
Priority to CN202280040671.3A priority patent/CN117501123A/zh
Priority to US18/570,499 priority patent/US20240385191A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
GBGB2108802.6A 2021-06-18 2021-06-18 Collagen type XX assay Ceased GB202108802D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB2108802.6A GB202108802D0 (en) 2021-06-18 2021-06-18 Collagen type XX assay
PCT/EP2022/066635 WO2022263675A1 (en) 2021-06-18 2022-06-17 Collagen type xx assay
JP2023574821A JP2024525130A (ja) 2021-06-18 2022-06-17 Ｘｘ型コラーゲンのアッセイ
EP22735384.4A EP4356137B1 (en) 2021-06-18 2022-06-17 Collagen type xx assay
KR1020237041627A KR20240022470A (ko) 2021-06-18 2022-06-17 Xx형 콜라겐 분석
CN202280040671.3A CN117501123A (zh) 2021-06-18 2022-06-17 Xx型胶原蛋白测定
US18/570,499 US20240385191A1 (en) 2021-06-18 2022-06-18 Collagen Type XX Assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2108802.6A GB202108802D0 (en) 2021-06-18 2021-06-18 Collagen type XX assay

Publications (1)

Publication Number Publication Date
GB202108802D0 true GB202108802D0 (en) 2021-08-04

Family

ID=77050621

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2108802.6A Ceased GB202108802D0 (en) 2021-06-18 2021-06-18 Collagen type XX assay

Country Status (7)

Country Link
US (1) US20240385191A1 (https=)
EP (1) EP4356137B1 (https=)
JP (1) JP2024525130A (https=)
KR (1) KR20240022470A (https=)
CN (1) CN117501123A (https=)
GB (1) GB202108802D0 (https=)
WO (1) WO2022263675A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011051278A1 (en) * 2009-10-26 2011-05-05 Externautics S.P.A. Lung tumor markers and methods of use thereof
CN108546760A (zh) * 2018-04-24 2018-09-18 郑州大学第附属医院 一种胰腺癌预后分子标志物非编码RNA Lnc-COL20A1-2及其应用

Also Published As

Publication number Publication date
JP2024525130A (ja) 2024-07-10
US20240385191A1 (en) 2024-11-21
WO2022263675A1 (en) 2022-12-22
EP4356137C0 (en) 2025-07-23
EP4356137B1 (en) 2025-07-23
KR20240022470A (ko) 2024-02-20
CN117501123A (zh) 2024-02-02
EP4356137A1 (en) 2024-04-24

Similar Documents

Publication Publication Date Title
GB202011617D0 (en) Assay
GB2616452B (en) Assay
GB202108802D0 (en) Collagen type XX assay
GB201908709D0 (en) Methacrylated collagen
IL307174A (en) examination
GB201901710D0 (en) Collagen type 23 assay
GB201712071D0 (en) Collagen type X alpha-1 assay
GB202209866D0 (en) Cross linked collagen type v assay
GB202307576D0 (en) C3a1-hne assay
GB202301141D0 (en) Pro-c5 assay
GB202218042D0 (en) Pro-C9 assay
GB202004195D0 (en) Type XIX collagen assay
GB202215897D0 (en) Neostatin-14 assay
GB202213495D0 (en) Cilp-m assay
GB202119033D0 (en) Assay
GB202117513D0 (en) Assay
GB202115072D0 (en) Assay
GB202115077D0 (en) Assay
GB202112296D0 (en) Assay
GB202109886D0 (en) Assay
GB202108853D0 (en) Assay
GB202105117D0 (en) Assay
GB202015211D0 (en) Assay
GB202015122D0 (en) Assay
GB202014570D0 (en) Complementome assay

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)